The gene therapy market is projected to grow at an annualized rate of 45%

Albert Brando

- 23-Mar-2021

Roots Analysis has done a detailed study on Gene Therapy Market (3rd Edition), 2019-2030”. covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

The gene therapy market is projected to grow at an annualized rate of 45%, till 2030

Roots Analysis has done a detailed study on Gene Therapy Market (3rd Edition), 2019-2030”. covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

To order this 670+ page report, which features 190+ figures and 340+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/gene-therapies-market/268.html

Key Market Insights

In the past four years, more than 31,000 patents related to gene therapies and gene editing have been filed / granted; this is indicative of the heightened pace of research in this domain
Presently, there are more than 10 approved gene therapies; over 465 product candidates are being evaluated for the treatment of a variety of disease indications
Most of the therapeutic leads are in the early stages of clinical development; a variety of viral and non-viral vectors are being used to introduce different types of gene modifications in such therapies
Although start-ups and mid-sized companies are spearheading the innovation, several big biopharmaceutical companies are also actively engaged
With multiple approved products and several under development, price is one of the major concerns in this market; the future is likely to witness the establishment of more affordable pricing and reimbursement strategies
As several candidates progress towards approval, developers are exploring diverse commercialization strategies to be implemented across different stages of a product’s launch cycle
CMOs offering vector manufacturing services have become an integral part of the gene therapy supply chain, owing to their ability to overcome the various associated challenges
Several investors, having realized the untapped opportunity within this emerging segment of genetic disorders, have invested over USD 16.5 billion across 280 instances, in the period between 2014 and 2019
Overall, prevalent trends indicate that the market for gene therapies is poised to grow significantly as multiple late stage molecules get commercialized in the near future for the treatment of different therapeutic areas
The projected future opportunity is expected to be distributed across different types of gene modifications, therapy delivery routes and key geographical regions